UBE2A and melanoma: Whole exome sequence (WES) analysis of clinical melanomas verified that while RAD6A variants represent only a small portion of the RAD6A transcripts in melanomas, RAD6B variants are co-expressed in 100% of the melanomas analyzed and represent the majority of the RAD6B transcriptome.